Cargando…
Nonsteroidal Antiinflammatory Drugs and Susceptibility to COVID‐19
OBJECTIVE: To identify whether active use of nonsteroidal antiinflammatory drugs (NSAIDs) increases susceptibility to developing suspected or confirmed coronavirus disease 2019 (COVID‐19) compared to the use of other common analgesics. METHODS: We performed a propensity score–matched cohort study wi...
Autores principales: | Chandan, Joht Singh, Zemedikun, Dawit Tefra, Thayakaran, Rasiah, Byne, Nathan, Dhalla, Samir, Acosta‐Mena, Dionisio, Gokhale, Krishna M., Thomas, Tom, Sainsbury, Christopher, Subramanian, Anuradhaa, Cooper, Jennifer, Anand, Astha, Okoth, Kelvin O., Wang, Jingya, Adderley, Nicola J., Taverner, Thomas, Denniston, Alastair K., Lord, Janet, Thomas, G. Neil, Buckley, Christopher D., Raza, Karim, Bhala, Neeraj, Nirantharakumar, Krishnarajah, Haroon, Shamil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252419/ https://www.ncbi.nlm.nih.gov/pubmed/33185016 http://dx.doi.org/10.1002/art.41593 |
Ejemplares similares
-
Renin-angiotensin system inhibitors and susceptibility to COVID-19 in patients with hypertension: a propensity score-matched cohort study in primary care
por: Haroon, Shamil, et al.
Publicado: (2021) -
Cluster analysis of patients with granulomatosis with polyangiitis (GPA) based on clinical presentation symptoms: a UK population-based cohort study
por: Thayakaran, Rasiah, et al.
Publicado: (2022) -
Association of Metformin with Susceptibility to COVID-19 in People with Type 2 Diabetes
por: Wang, Jingya, et al.
Publicado: (2021) -
Sodium‐glucose co‐transporter‐2 inhibitors and susceptibility to COVID‐19: A population‐based retrospective cohort study
por: Sainsbury, Christopher, et al.
Publicado: (2020) -
Angiotensin‐converting enzyme inhibitors and risk of age‐related macular degeneration in individuals with hypertension
por: Subramanian, Anuradhaa, et al.
Publicado: (2022)